Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torgrim Tandstad

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of Public Health Research|January 30, 2026
Breast cancer and long-term employment: A retrospective cohort study from NorwayRoy A Nielsen, Eliva Atieno Ambugo, Steffen Torp, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2014
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocolsTorgrim Tandstad, Arne Solberg, Ulf Håkansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2022
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic FactorsSophie D Fosså, Alv A Dahl, Lene Thorsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2020
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survivalSophie D Fosså, Kirsti Aas, Christoph Müller, et al.
Anticancer Research|March 10, 2015
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up studyLine V Hjelle, Per O M Gundersen, Jan Oldenburg, et al.
European Urology Open Science|February 3, 2025
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical ChallengeSophie D Fosså, Lars J Bjerner, Torgrim Tandstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management programTorgrim Tandstad, Olav Dahl, Gabriella Cohn-Cedermark, et al.
Clinical Genitourinary Cancer|February 6, 2026
Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular CancerHelene F S Negaard, Hege S Haugnes, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort StudyRagnhild Hellesnes, Tor Åge Myklebust, Roy M Bremnes, et al.
Plos Medicine|June 5, 2019
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register studyYahia Al-Jebari, Ingrid Glimelius, Carina Berglund Nord, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of Public Health Research|January 30, 2026
Breast cancer and long-term employment: A retrospective cohort study from NorwayRoy A Nielsen, Eliva Atieno Ambugo, Steffen Torp, et al.
Acta Oncologica (Stockholm, Sweden)|September 6, 2014
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocolsTorgrim Tandstad, Arne Solberg, Ulf Håkansson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2022
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic FactorsSophie D Fosså, Alv A Dahl, Lene Thorsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2020
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survivalSophie D Fosså, Kirsti Aas, Christoph Müller, et al.
Anticancer Research|March 10, 2015
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up studyLine V Hjelle, Per O M Gundersen, Jan Oldenburg, et al.
European Urology Open Science|February 3, 2025
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical ChallengeSophie D Fosså, Lars J Bjerner, Torgrim Tandstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management programTorgrim Tandstad, Olav Dahl, Gabriella Cohn-Cedermark, et al.
Clinical Genitourinary Cancer|February 6, 2026
Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular CancerHelene F S Negaard, Hege S Haugnes, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort StudyRagnhild Hellesnes, Tor Åge Myklebust, Roy M Bremnes, et al.
Plos Medicine|June 5, 2019
Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register studyYahia Al-Jebari, Ingrid Glimelius, Carina Berglund Nord, et al.
Pageof 7